<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03473652</url>
  </required_header>
  <id_info>
    <org_study_id>APPAHOCA</org_study_id>
    <nct_id>NCT03473652</nct_id>
  </id_info>
  <brief_title>Feasibility of Adapted Physical Activity Based on a Walking Platform in Hospitalized Old Patients for Cancer</brief_title>
  <acronym>APPAHOCA</acronym>
  <official_title>Feasibility of Adapted Physical Activity Based on a Walking Platform in Hospitalized Old Patients for Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Francois Baclesse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Francois Baclesse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigator propose to evaluate the interest of the provision of a suitable treadmill
      offering fall protection and verticalization assistance.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 29, 2018</start_date>
  <completion_date type="Actual">December 11, 2018</completion_date>
  <primary_completion_date type="Actual">October 11, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient adherence to use a walking Platform</measure>
    <time_frame>2 days</time_frame>
    <description>Adapted physical activity on a walking platform will be considered feasible if &gt; or = to 70% of patients perform &gt; or = to 2 sessions of 6 minutes or more during hospitalization for cancer lasting &gt; or = to 48h</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Oncology</condition>
  <condition>Adapted Physical Activity</condition>
  <arm_group>
    <arm_group_label>Adapted walking platform</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Adapted walking platform</intervention_name>
    <description>The walking sessions will be carried out on a suitable walking platform, including a connected play tablet.</description>
    <arm_group_label>Adapted walking platform</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with cancer

          -  Patient over 70 years old hospitalized 48 hours or more

          -  Patient identified as eligible for medical prescription of Adapted physical activity

          -  Mastery of the French language ;

          -  Patient affiliated to a social security scheme

          -  Patient giving written consent

        Exclusion Criteria:

          -  Patient totally unable to communicate

          -  Patient in terminal palliative care

          -  Patient with a size &lt;1m35 or&gt; 2m and / or a weight&gt; 130kg

          -  Patient unable to perform Adapted physical activity sessions

          -  Patient unable to wear a restraint harness.

          -  Patient deprived of liberty or under guardianship

          -  Patient unable to comply with protocol requirements for geographical, social or
             psychopathological reasons
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centre Fran√ßois Baclesse</name>
      <address>
        <city>Caen</city>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU</name>
      <address>
        <city>Caen</city>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <study_first_submitted>March 12, 2018</study_first_submitted>
  <study_first_submitted_qc>March 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2018</study_first_posted>
  <last_update_submitted>January 15, 2019</last_update_submitted>
  <last_update_submitted_qc>January 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

